These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2004-004464-69||A Home Based Phase IIb, Multi-centre, Randomised, Double-Blind, Placebo Controlled, Dose Finding Parallel Group Study to explore the Optimal Dose of Inhaled VR004 in Patients with Erectile Dysfunction...||2006-05-03||due-trials|
|Reported results||2005-004065-42||Phase II, double blind, intermittent dose, placebo controlled, randomised, two period crossover study to investigate the effect of inhaled doses of VR776 administered via Aspirair inhaler on IVELT (in...||2007-03-15||due-trials|
|Reported results||2005-005120-13||A clinic based, Phase IIa, randomised, double-blind, placebo-controlled, ascending dose, single centre study investigating the safety, tolerability, efficacy, and pharmacokinetics of VR040 in patients...||2006-05-31||due-trials|
|Completed, but no date, and reported results||2005-005476-32||A Phase IIb, Randomised, Double-Blind, Placebo Controlled, Dose Finding Study Assessing the Haemodynamic Safety and "At Home" Efficacy of Inhaled VR004 in patients with Erectile Dysfunction (ED).||bad-data|
|Not reported||2006-004582-33||A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Escalating Study Investigating the Efficacy and Safety of VR040 in the Treatment of Unpredictable “Off” or End-of-Dose “Wearing Off...||2006-11-03||due-trials|
|Reported results||2006-005509-79||A Clinic-Based, Phase IIa, Randomised, Double-Blind, Placebo-Controlled, Ascending-Dose, Multicentre Study Investigating the Safety, Tolerability, Efficacy, and Pharmacokinetics of VR040 in Patients w...||2007-08-29||due-trials|
|Reported results||2007-006276-11||A Phase I/II randomised, placebo-controlled, double blind trial to assess the safety, tolerability, pharmacodynamics and exploratory efficacy of heparin 25 mg inhalation powder in adults with Cystic F...||2010-10-25||due-trials|
|Reported results||2008-004447-11||A Phase IIb Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study Investigating the Efficacy and Safety of Apomorphine Inhalation Powder in Patients With On-Off or Wearing-Off Effe...||2010-07-15||due-trials|
|Reported results||2011-001772-19||A randomised, double-blind, placebo controlled, parallel group, study to evaluate the efficacy and safety of VR506 inhalation powder from a new dry powder inhaler in adolescent and adult subjects with...||2013-05-09||due-trials|
|Reported results||2011-005030-19||A randomised double-blind, parallel group, dose-ranging study to evaluate the efficacy and safety of three different total daily doses of fluticasone propionate inhaled from a new dry powder inhaler i...||2013-10-31||due-trials|
|Reported results Terminated||2012-004072-19||A randomized, double-blind, parallel group, placebo controlled Phase II study to evaluate the safety and efficacy of inhaled LASAG and Placebo, applied three times daily in adult hospitalized patients...||2015-05-06||due-trials|
|Trial is partly outside EEC, and reported results||2015-000353-20||A randomised, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of two doses of nebulised budesonide delivered by the VR475 Inhalation System, with an open-lab...||2018-09-27||bad-data|